[27I-pm] 臨床生化学/疾病と遺伝子・遺伝子治療

Fri. Mar 27, 2020 1:45 PM - 3:21 PM [Room I] Room I (2F)

Chair: Takehiro Kawashiri, Shunsaku Nakagawa

+Add all to schedule

1:45 PM - 1:57 PM

[27I-pm01S] Relationship between plasma N-acetylglucosamine concentration and disease activity in patients with rheumatoid arthritis

○Akira Imae¹, Seiji Tsuboi^1,2, Satoru Nagumo¹, Yasuharu Yazawa¹, Takashi Osawa¹, Yoshiyuki Kagawa¹ (1. Sch.Pharm.Sci., Univ. Shizuoka, 2. Rheumatology. Shizuoka Welfare Hosp.)

1:57 PM - 2:09 PM

[27I-pm02S] An exploratory study assesing the clinical significance of cholesterol efflux capacity in patients with Myocardial infarction

○Erika Matsumoto¹, Kentarou Oniki², Masatsune Ogura³, Yuri Seguchi¹, Momoka Saitou¹, Yuki Sakamoto², Tadashi Imafuku², Hiroshi Watanabe², Toru Maruyama², Kouji Otake⁵, Yasuhiro Ogata⁵, Yuichirou Arima⁴, Kenichi Tsujita⁴, Mariko Shiba³, Junji Saruwatari² (1. Pharm. Sci.,Kumamoto Univ., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ., 3. National Cerebral and Cardiovascular Center, 4. Cardiovascular Medicine, Grad. Sch.,Medical Sci.,Kumamoto Univ., 5. Japanese Red Cross Kumamoto Health Care Center)

2:09 PM - 2:21 PM

[27I-pm03S] Multifaceted study on factors affecting the activity of SCD1, a fatty acid desaturase, for the prevention of lifestyle-related diseases.

○Naoto Tokumaru¹, Kentaro Oniki², Takao Sato³, Momoka Saito¹, Erika Matsumoto¹, Yasuhiro Ogata⁴, Koji Otake⁴, Tadashi Imafuku², Hiroshi Watanabe², Toru Maruyama², Junji Saruwatari² (1. Pharm. Sci., Kumamoto Univ., 2. Grad. Pharm. Sci., Kumamoto Univ., 3. Kumamoto Industrial Resarch Institute., 4. Japanese Red Cross Kumamoto Health Care Center.)

2:21 PM - 2:33 PM

[27I-pm04S] Optimization of the E1 gene expression cassette for development of an efficient oncolytic adenovirus

○Fumitaka Nishimae¹, Kosuke Takayama¹, Fuminori Sakurai¹, Hiroyuki Mizuguchi^1,2,3,4 (1. Grad.Sch.Pharm.Osaka Univ, 2. NIBIOHN, 3. Ctr MEI,Osaka Univ, 4. OTRI,Osaka Univ)

2:33 PM - 2:45 PM

[27I-pm05S] The role of the novel target gene of NASH/NAFLD-related microRNA miR-27b in lipid breakdown

○Toshiki Fujimoto¹, Eiko Sakai¹, Ruruka Suzuki¹, Fuminori Sakurai¹, Hiroyuki Mizuguchi^1,3,2,4 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. Ctr MEI, Osaka Univ, 4. OTRI)

2:45 PM - 2:57 PM

[27I-pm06S] Development of a novel technique to reverse endothelial to mesenchymal transition.

○Kohei Izawa¹, Aki Yoneda², Tomoaki Kambara², Yoshiaki Okada¹, Takefumi Doi¹ (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Sch. Pharm. Sci., Osaka Univ.)

2:57 PM - 3:09 PM

[27I-pm07S] Involvement of the single nucleotide polymorphism in the μ-opioid receptor gene in athma severity.

○Mayumi Harada¹, Tomomitu Miyasaka¹, Kaori Kawakami¹, Yutaka Nakamura², Satoshi Miyata³, Miki Sato¹, Hirohito Metoki², Ichiro Sora⁴, Kohei Yamauchi⁵, Tasuku Kawano¹, Hiroaki Shimokawa³, Motoaki Takayanagi¹, Tomoko Takahashi¹, Isao Ohno² (1. Fact. Pharm. Sci., Tohoku Med. and Pharm. Univ., 2. Fact. Med., Tohoku Med. and Pharm. Univ., 3. Grad. Sch. Med., Tohoku Univ., 4. Grad. Sch. Med., Kobe Univ., 5. Dept. Int. Med., Takizawa Cent. Hosp.)

3:09 PM - 3:21 PM

[27I-pm08] Basic research for development of novel anticancer drags targeting tetraspanin CD81 gene

○Tohru Nakanishi¹, Tsutomu Yamasaki², Naoki Mizoshiri³, Toshiharu Shirai³, Yuji Arai³ (1. Grad. Sch. Pharm. Shujitsu Univ., 2. Sch. Pharm. Shujitsu Univ., 3. Grad. Sch. Med. Kyoto Pref. Univ. Med)

Session information